STAY IN TOUCH! SUBSCRIBE TO OUR EMAIL NEWSLETTER
Understanding Nervous System Tumors: Types, Symptoms, Diagnosis, and Care
Nervous system tumors are abnormal growths that arise in or around the structures responsible for communication throughout the body. They may develop in the central nervous system (CNS), comprising the brain and spinal cord, or in the peripheral nervous system (PNS), the network of nerves outside these structures. Their effects depend in part on their location: a relatively small growth may interfere with nearby tissue, while a larger growth elsewhere may cause different problems. The term encompasses a broad group of conditions rather than a single disease.
PATIENT EDUCATIONPATIENT CARE
Viswanath M. Aluru, M.D.
11/3/20265 min read
Nervous system tumors are abnormal growths that arise in or around the structures responsible for communication throughout the body. They may develop in the central nervous system (CNS), comprising the brain and spinal cord, or in the peripheral nervous system (PNS), the network of nerves outside these structures. Their effects depend in part on their location: a relatively small growth may interfere with nearby tissue, while a larger growth elsewhere may cause different problems. The term encompasses a broad group of conditions rather than a single disease.
An important distinction is whether a tumor is primary or metastatic. A primary tumor originates in nervous-system tissue or a related structure. A metastatic tumor reaches the brain, spinal cord, or nerves after cancer spreads from another part of the body. Primary CNS tumors are also classified according to the cells or structures from which they arise. Glial tumors develop from glial cells, which support and protect nerve cells. Non-glial tumors arise from other cell types or structures, such as the coverings of the brain and spinal cord. These categories help clinicians describe a tumor but do not, by themselves, determine its behavior or treatment.
These growths can occur at any age, from childhood to older adulthood, although certain types are more common in specific age groups. They vary considerably in location, growth rate, and biological behavior. Some are noncancerous and slow-growing; others are cancerous, may grow or spread more aggressively, or require urgent attention because of their location. A tumor’s name or category alone cannot predict an individual outcome. Causes and risk factors also vary by type. Genetic changes and family history may contribute in some cases, but many people have no identifiable inherited cause. Certain environmental exposures may be relevant to specific gene mutations; however, a tumor should not be attributed to an exposure without supporting evidence.
Symptoms of a nervous system tumor vary considerably. They depend on the tumor’s location, size, and growth pattern, as well as whether it affects nearby nerves, brain tissue, or other structures. A tumor may also increase pressure within the skull, causing symptoms that differ from those associated with its specific location. Some people initially experience few noticeable signs, while others develop symptoms that become more apparent over time.
Possible symptoms include persistent or worsening headaches, seizures, nausea or vomiting, and focal neurological difficulties. These may include weakness or altered sensation in part of the body, or problems with speech or vision. Changes in memory, concentration, behavior, or personality may also occur, particularly when areas involved in these functions are affected. The pattern of symptoms can provide clinicians with useful information, but it cannot identify a tumor on its own. Headaches, seizures, and neurological changes have many possible causes, and experiencing one or more of them does not establish a tumor diagnosis.
A detailed neurological examination is an important component of clinical assessment. A clinician may evaluate strength, sensation, coordination, reflexes, vision, speech, balance, and cognitive function. These assessments help identify potentially affected functions and determine whether further investigation is indicated. The examination may also guide the selection or interpretation of imaging tests, such as MRI or CT scans. Documented results provide a baseline for comparison with later assessments, helping clinicians monitor changes over time or evaluate response to care.
Urgent assessment is warranted for a first seizure, sudden neurological changes, or symptoms that are severe and rapidly worsening. Examples include sudden weakness, new difficulty speaking, abrupt vision loss, or a severe headache that escalates quickly. Prompt medical evaluation enables clinicians to assess potentially serious causes and determine appropriate next steps. For persistent or gradually changing symptoms, arranging a timely appointment with a healthcare professional can help clarify their cause and whether further testing is appropriate.
Diagnosis of a nervous system tumor begins with a review of symptoms, medical history, and overall health. A clinician may ask when symptoms began, how they have changed, and whether there is a history of cancer or conditions affecting the nervous system. A neurological examination assesses functions such as strength, sensation, balance, coordination, vision, reflexes, and memory. These findings help guide the selection of tests and provide a baseline for later comparison. Diagnosis generally combines clinical information and imaging rather than relying on a single symptom or test.
Computed tomography (CT) can be useful when rapid assessment is needed, including in some urgent situations, and may reveal bleeding, swelling, or other changes. Magnetic resonance imaging (MRI) is a key method for detailed evaluation of the brain, spinal cord, and surrounding structures. Different MRI sequences highlight different tissue characteristics. T2-weighted and FLAIR images, for example, can help clinicians characterize an abnormality and assess its relationship to nearby tissue. In selected cases, MR spectroscopy provides additional information about chemical patterns within a lesion. However, it is a specialized imaging technique and does not replace standard imaging, clinical assessment, or tissue analysis when those are indicated.
Imaging may suggest a tumor type, but a biopsy or tissue collected during surgery can establish the diagnosis and reveal features that help guide care. Tissue sampling is considered when the information it is expected to provide is useful and the risks of the procedure are acceptable. Decisions depend on factors such as the lesion’s location, the person’s health, the risks of accessing the area, and whether the results would affect treatment planning. A biopsy is not appropriate or necessary in every case. If scans raise concern for metastases, clinicians may also investigate whether a cancer originated elsewhere in the body. The tests used for this purpose are tailored to the individual’s history, examination, imaging findings, and overall clinical situation.
Treatment for a nervous system tumor is individualized and is not determined by diagnosis alone. Clinicians consider the tumor’s type and grade or behavior, its location and extent, the symptoms it causes, the person’s overall health, and their preferences and goals. These factors inform whether treatment aims to remove or control the tumor, relieve symptoms, preserve neurological function, or combine several objectives.
For primary tumors, surgery may be recommended to remove as much tumor tissue as can be reached safely, or to reduce the tumor’s size when complete removal is not feasible. Radiotherapy and chemotherapy may also be used, either alone or in combination with surgery. The sequence and combination of treatments depend on the tumor and the person’s circumstances. In selected cases, adjuvant chemotherapy is given after another treatment to address possible residual disease or reduce the risk of recurrence. The care team explains the expected benefits, limitations, and potential side effects of each option.
Metastatic tumors in the nervous system have spread from cancer elsewhere in the body. Common primary sites include the lung, breast, skin (including melanoma), gastrointestinal tract, and kidney. Care may include treatment directed at the underlying cancer, radiation to one or more tumor sites, or surgery or tumor debulking in selected circumstances. Clinicians may prescribe systemic corticosteroids to reduce swelling around a tumor; these medicines require professional guidance and monitoring. The approach depends on the extent of disease, symptoms, and overall treatment plan.
For metastases, care may focus on controlling disease and symptoms, protecting neurological function, and prolonging or improving quality of life. Decisions are generally made by a multidisciplinary team that may include specialists in neurology, neurosurgery, oncology, and radiation oncology. Patients and families can discuss how different options align with their priorities and ask about their likely effects on daily life. Supportive and palliative care can be integrated with tumor-directed treatment at any stage, helping address symptoms, practical needs, and emotional concerns while treatment continues.
